CIWA-Ar
Max score 67. No Rx for score under 10
Assesses the severity of alcohol withdrawal symptoms to guide management.
Indications for Use
Used to assess alcohol withdrawal severity in communicative adults and to guide symptom‑triggered benzodiazepine dosing. Validated to track withdrawal course and correlate with treatment response 1 [Level II evidence]. Symptom‑triggered protocols using CIWA‑Ar reduce benzodiazepine exposure and length of stay without added adverse events 2 [Level II evidence]. Not reliable in ICU or non‑communicative patients.
Insights & Cautions
Start with cautious, symptom‑triggered use; requires a communicative, non‑delirious, medically stable patient. It reliably tracks withdrawal severity and guides benzodiazepine dosing but is subjective and misleading in ICU, postoperative states, delirium, language barriers, or nonverbal patients 1. Overuse in low‑risk or poorly selected patients increases benzodiazepine exposure and adverse events 2. Use clinical judgment and alternative objective scales when communication is impaired.